Lawrence Livermore National Laboratory, 7000 East Avenue, Livermore, CA 94550

A -- LAWRENCE LIVERMORE NATIONAL LABORATORY SEEKS PARTNERSHIPS WITH INDUSTRY TO COMMERCIALIZE ANTIBODIES TO DNA REPAIR PROTEINS SOL CBD00-005 DUE 030600 POC Industrial Partnerships and Commercialization (925) 422-6416 Announcement: Lawrence Livermore National Laboratory (LLNL), operated by the University of California under contract with the U.S. Department of Energy (DOE), is seeking one or more industrial partners to commercialize monoclonal antibodies to DNA repair proteins. LLNL has developed numerous monoclonal antibodies to DNA repair proteins XPF, XRCC1, RAD1, POLB, ERCC1, and EXO1. There are multiple hybridoma cell lines producing antibodies for each of these DNA repair proteins and some antibodies, but not all, have been characterized as to epitope, IgG type, media titer and cross-reactivity. LLNL will license these antibodies to be sold for R&D purposes only. Note: THIS IS NOT A PROCUREMENT. Parties interested in commercializing LLNL's antibodies to DNA repair proteins should provide a written statement of interest including a commercialization plan and a description of corporate capabilities relevant to their commercialization. Written responses should be directed to: Lawrence Livermore National Laboratory Industrial Partnerships and Commercialization Office P. O. Box 808, L-795 Livermore, CA 94551 Attention: CBD00-005 Please provide your written statement within sixty (60) days from the date this announcement is printed to ensure consideration of your interest in commercializing these antibodies. Posted 01/05/00 (W-SN413309). (0005)

Loren Data Corp. http://www.ld.com (SYN# 0002 20000107\A-0002.SOL)